Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20233631
- Approval Date
- May 29, 2023
NMPA
Balanced Salt Solution Irrigating
- Product Name
- 平衡盐溶液(供灌注用)
- Approval Number
- 国药准字H20233038
- Approval Date
- Jan 10, 2023
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20223332
- Approval Date
- May 25, 2022
NMPA
Brimonidine Tartrate Eye Drops
- Product Name
- 酒石酸溴莫尼定滴眼液
- Approval Number
- 国药准字H20163241
- Approval Date
- Jul 14, 2021
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20203419
- Approval Date
- Aug 12, 2020
NMPA
Clinical Trials
No trials found
News
No news found